Human Technologies, Inc. Fundamental Analysis
Human Technologies, Inc. (5621.T) shows moderate financial fundamentals with a PE ratio of 12.60, profit margin of 13.56%, and ROE of 20.73%. The company generates $7.5B in annual revenue with N/A year-over-year growth of N/A.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 75.2/100 based on profitability, valuation, growth, and balance sheet metrics. The B grade reflects solid fundamentals with room for improvement in valuation or growth.
Fundamental Health Score
We analyze 5621.T's fundamental strength across five key dimensions:
Efficiency Score
Excellent5621.T demonstrates superior asset utilization.
Valuation Score
Excellent5621.T trades at attractive valuation levels.
Growth Score
Moderate5621.T shows steady but slowing expansion.
Financial Health Score
Excellent5621.T maintains a strong and stable balance sheet.
Profitability Score
Weak5621.T struggles to sustain strong margins.
Key Financial Metrics
Is 5621.T Expensive or Cheap?
P/E Ratio
5621.T trades at 12.60 times earnings. This suggests potential undervaluation.
PEG Ratio
When adjusting for growth, 5621.T's PEG of 0.23 indicates potential undervaluation.
Price to Book
The market values Human Technologies, Inc. at 2.43 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at 11.04 times EBITDA. This signals the market has high growth expectations.
How Well Does 5621.T Make Money?
Net Profit Margin
For every $100 in sales, Human Technologies, Inc. keeps $13.56 as profit after all expenses.
Operating Margin
Core operations generate 18.28 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $20.73 in profit for every $100 of shareholder equity.
ROA
Human Technologies, Inc. generates $14.97 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Human Technologies, Inc. generates limited operating cash flow of $0.00, signaling weaker underlying cash strength.
Free Cash Flow
Human Technologies, Inc. generates weak or negative free cash flow of $0.00, restricting financial flexibility.
FCF Per Share
Each share generates $0.00 in free cash annually.
FCF Yield
5621.T converts 0.00% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
12.60
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
0.23
vs 25 benchmark
P/B Ratio
Price to book value ratio
2.43
vs 25 benchmark
P/S Ratio
Price to sales ratio
1.71
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.00
vs 25 benchmark
Current Ratio
Current assets to current liabilities
3.89
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.21
vs 25 benchmark
ROA
Return on assets percentage
0.15
vs 25 benchmark
ROCE
Return on capital employed
0.26
vs 25 benchmark
How 5621.T Stacks Against Its Sector Peers
| Metric | 5621.T Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 12.60 | 41.62 | Better (Cheaper) |
| ROE | 20.73% | 778.00% | Weak |
| Net Margin | 13.56% | 10827298377.00% | Weak |
| Debt/Equity | 0.00 | 0.45 | Strong (Low Leverage) |
| Current Ratio | 3.89 | 5.29 | Strong Liquidity |
| ROA | 14.97% | 151.00% | Weak |
5621.T outperforms its industry in 3 out of 6 key metrics, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Human Technologies, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
N/A
Industry Style: Growth, Innovation, High Beta
EPS CAGR
N/A
Industry Style: Growth, Innovation, High Beta
FCF CAGR
N/A
Industry Style: Growth, Innovation, High Beta